Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for ERG
Z-value: 3.34
Motif logo
Transcription factors associated with ERG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ERG
|
ENSG00000157554.19 | ETS transcription factor ERG |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ERG | hg38_v1_chr21_-_38660656_38660681 | 0.22 | 2.2e-01 | Click! |
Activity profile of ERG motif
Sorted Z-values of ERG motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ERG
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.0 | 35.0 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 6.4 | 19.1 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
| 5.8 | 17.4 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 5.1 | 5.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
| 4.9 | 14.7 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 4.5 | 17.9 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
| 4.1 | 20.6 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 3.9 | 15.7 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 3.6 | 10.8 | GO:0061485 | memory T cell proliferation(GO:0061485) |
| 3.5 | 10.5 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 3.3 | 22.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 3.2 | 41.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 3.0 | 12.1 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 2.9 | 8.7 | GO:0071663 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 2.7 | 8.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 2.7 | 8.2 | GO:0035744 | T-helper 1 cell cytokine production(GO:0035744) |
| 2.7 | 8.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 2.7 | 13.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.7 | 10.7 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 2.6 | 7.9 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.6 | 2.6 | GO:1903970 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 2.5 | 17.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 2.5 | 20.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 2.5 | 7.5 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 2.5 | 7.5 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 2.5 | 4.9 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 2.2 | 6.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 2.2 | 11.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 2.2 | 8.8 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 2.2 | 8.7 | GO:0052552 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 2.1 | 6.4 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 2.1 | 8.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 2.0 | 6.1 | GO:0032681 | negative regulation of T cell tolerance induction(GO:0002665) negative regulation of T cell anergy(GO:0002668) negative regulation of lymphocyte anergy(GO:0002912) regulation of lymphotoxin A production(GO:0032681) positive regulation of lymphotoxin A production(GO:0032761) regulation of lymphotoxin A biosynthetic process(GO:0043016) positive regulation of lymphotoxin A biosynthetic process(GO:0043017) |
| 2.0 | 6.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 2.0 | 13.8 | GO:0032252 | secretory granule localization(GO:0032252) |
| 2.0 | 11.7 | GO:0050904 | diapedesis(GO:0050904) |
| 1.9 | 13.6 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 1.9 | 9.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 1.9 | 1.9 | GO:0045399 | regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 1.9 | 5.6 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.9 | 13.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 1.9 | 5.6 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.8 | 14.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.8 | 3.6 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 1.7 | 7.0 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.7 | 19.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.7 | 27.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 1.7 | 5.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.7 | 5.2 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
| 1.7 | 1.7 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 1.7 | 6.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.7 | 5.0 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
| 1.6 | 8.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 1.6 | 4.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.6 | 14.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 1.6 | 6.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.6 | 7.9 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
| 1.6 | 6.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 1.6 | 4.7 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.6 | 4.7 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.6 | 1.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 1.5 | 9.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 1.5 | 7.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 1.5 | 8.8 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 1.5 | 16.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.4 | 5.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.4 | 24.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 1.4 | 5.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 1.4 | 14.0 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.4 | 4.2 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 1.4 | 4.1 | GO:1903489 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 1.4 | 27.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.3 | 10.7 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 1.3 | 4.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.3 | 4.0 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 1.3 | 7.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 1.3 | 5.2 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.3 | 11.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 1.3 | 2.6 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 1.3 | 3.9 | GO:0021503 | neural fold bending(GO:0021503) |
| 1.3 | 6.4 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.3 | 3.8 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
| 1.3 | 8.9 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.2 | 12.3 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
| 1.2 | 2.5 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 1.2 | 2.4 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 1.2 | 15.9 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 1.2 | 25.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.2 | 8.4 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.2 | 9.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.2 | 31.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 1.2 | 3.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.1 | 4.6 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.1 | 3.4 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 1.1 | 15.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 1.1 | 3.4 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 1.1 | 3.3 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.1 | 3.3 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 1.1 | 6.6 | GO:0002729 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of natural killer cell cytokine production(GO:0002729) |
| 1.1 | 5.5 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 | 3.3 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 1.1 | 97.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 1.1 | 3.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.1 | 7.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 1.1 | 6.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.1 | 1.1 | GO:0002339 | B cell selection(GO:0002339) |
| 1.0 | 6.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.0 | 4.2 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 1.0 | 14.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 1.0 | 1.0 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 1.0 | 4.1 | GO:0090135 | actin filament branching(GO:0090135) |
| 1.0 | 4.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.0 | 7.1 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 1.0 | 4.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 1.0 | 3.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 1.0 | 6.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.0 | 3.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) positive regulation of late endosome to lysosome transport(GO:1902824) |
| 1.0 | 7.0 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.0 | 3.0 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 1.0 | 3.0 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 1.0 | 3.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.0 | 24.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 1.0 | 3.9 | GO:0002384 | hepatic immune response(GO:0002384) |
| 1.0 | 3.9 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 1.0 | 2.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.9 | 3.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.9 | 2.8 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.9 | 7.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.9 | 14.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.9 | 10.2 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.9 | 3.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.9 | 5.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.9 | 1.8 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.9 | 4.6 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.9 | 14.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.9 | 4.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.9 | 2.7 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.9 | 1.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.9 | 4.4 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.9 | 8.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.9 | 0.9 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.9 | 13.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.9 | 5.3 | GO:0035696 | monocyte extravasation(GO:0035696) |
| 0.9 | 4.4 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.9 | 1.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.9 | 5.2 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.9 | 4.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.9 | 0.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.9 | 8.5 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.8 | 4.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.8 | 11.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.8 | 2.5 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.8 | 2.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.8 | 12.3 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.8 | 2.5 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.8 | 119.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.8 | 8.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.8 | 12.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.8 | 3.2 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.8 | 4.8 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.8 | 5.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.8 | 4.6 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 0.8 | 6.2 | GO:0048619 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.8 | 3.1 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.8 | 0.8 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.8 | 3.8 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.8 | 2.3 | GO:0035698 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.7 | 3.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.7 | 5.2 | GO:0051511 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.7 | 2.2 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.7 | 0.7 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.7 | 6.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.7 | 7.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.7 | 5.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.7 | 2.2 | GO:0045556 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.7 | 5.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.7 | 2.8 | GO:1900161 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 0.7 | 6.3 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.7 | 2.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.7 | 0.7 | GO:0071650 | negative regulation of chemokine (C-C motif) ligand 5 production(GO:0071650) |
| 0.7 | 4.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.7 | 6.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 | 4.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.7 | 5.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.7 | 2.7 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.7 | 2.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.7 | 3.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.7 | 2.7 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.7 | 2.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.7 | 140.8 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.7 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.7 | 3.3 | GO:0097403 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.7 | 2.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.7 | 14.4 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.7 | 2.0 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.6 | 2.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.6 | 2.6 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.6 | 5.8 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.6 | 1.9 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.6 | 1.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.6 | 1.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 3.8 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.6 | 8.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.6 | 15.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.6 | 10.0 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.6 | 5.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.6 | 10.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.6 | 20.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.6 | 0.6 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.6 | 9.8 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.6 | 1.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.6 | 2.4 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.6 | 12.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.6 | 8.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.6 | 2.4 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.6 | 0.6 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.6 | 1.8 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.6 | 2.4 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.6 | 13.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
| 0.6 | 19.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
| 0.6 | 1.7 | GO:0002769 | natural killer cell inhibitory signaling pathway(GO:0002769) |
| 0.6 | 48.2 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.6 | 5.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.6 | 9.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.6 | 1.1 | GO:2000307 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
| 0.6 | 3.9 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.6 | 3.3 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 0.6 | 2.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.6 | 1.7 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.5 | 4.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.5 | 1.6 | GO:0015734 | taurine transport(GO:0015734) |
| 0.5 | 4.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.5 | 2.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.5 | 16.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.5 | 0.5 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 0.5 | 3.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.5 | 1.0 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.5 | 3.1 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.5 | 4.6 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.5 | 1.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.5 | 3.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.5 | 13.7 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.5 | 12.7 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.5 | 6.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.5 | 1.5 | GO:0055099 | detection of hormone stimulus(GO:0009720) response to high density lipoprotein particle(GO:0055099) |
| 0.5 | 9.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.5 | 3.0 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.5 | 3.5 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.5 | 1.0 | GO:0043366 | beta selection(GO:0043366) |
| 0.5 | 1.0 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.5 | 1.0 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.5 | 2.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.5 | 2.0 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.5 | 8.3 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.5 | 1.0 | GO:1990169 | detoxification of copper ion(GO:0010273) regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) stress response to copper ion(GO:1990169) |
| 0.5 | 9.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.5 | 1.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.5 | 5.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.5 | 5.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.5 | 2.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.5 | 4.7 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
| 0.5 | 1.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.5 | 4.7 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.5 | 3.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.5 | 1.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.5 | 32.3 | GO:0042100 | B cell proliferation(GO:0042100) |
| 0.5 | 1.4 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.5 | 1.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 3.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.5 | 0.9 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.5 | 2.7 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.5 | 1.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.5 | 1.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 1.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.4 | 3.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.4 | 7.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.4 | 1.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.4 | 1.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.4 | 9.7 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.4 | 4.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.4 | 3.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.4 | 3.4 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.4 | 2.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.4 | 4.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.4 | 1.3 | GO:0070077 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.4 | 3.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 1.7 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.4 | 1.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.4 | 2.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.4 | 1.2 | GO:0100057 | regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.4 | 4.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 3.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 | 0.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.4 | 3.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 | 1.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.4 | 2.8 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.4 | 7.1 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.4 | 2.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.4 | 2.4 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.4 | 36.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.4 | 3.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.4 | 1.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.4 | 0.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.4 | 3.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.4 | 7.3 | GO:0019731 | antibacterial humoral response(GO:0019731) |
| 0.4 | 3.8 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.4 | 1.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.4 | 5.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.4 | 8.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.4 | 1.1 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.4 | 10.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.4 | 4.8 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 1.5 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 | 2.2 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.4 | 5.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.4 | 2.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.4 | 6.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.4 | 0.4 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.4 | 5.0 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
| 0.4 | 26.6 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.4 | 5.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 2.1 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.4 | 2.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 | 3.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 | 24.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.3 | 0.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.3 | 1.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
| 0.3 | 1.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 | 2.4 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.3 | 3.1 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.3 | 5.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.3 | 0.7 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.3 | 1.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.3 | 9.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 2.7 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
| 0.3 | 8.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.3 | 2.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.3 | 3.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.3 | 6.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 3.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 8.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 1.3 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.3 | 2.3 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.3 | 3.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 | 1.3 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.3 | 3.6 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.3 | 1.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.3 | 3.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 | 230.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.3 | 5.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 | 3.1 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.3 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.3 | 0.3 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.3 | 1.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 0.6 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.3 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.3 | 3.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.3 | 1.5 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.3 | 1.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.3 | 4.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.3 | 0.9 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.3 | 4.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.3 | 9.7 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
| 0.3 | 7.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.3 | 2.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 | 1.2 | GO:0046351 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) disaccharide biosynthetic process(GO:0046351) |
| 0.3 | 1.7 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.3 | 2.9 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 0.6 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 1.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 4.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 | 1.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.3 | 33.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.3 | 1.4 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.3 | 1.4 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.3 | 1.7 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 5.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 0.8 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.3 | 0.8 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 9.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.3 | 3.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.3 | 0.5 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.3 | 2.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.3 | 1.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.3 | 1.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.3 | 1.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.3 | 10.8 | GO:0038093 | Fc receptor signaling pathway(GO:0038093) |
| 0.3 | 1.8 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.3 | 0.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.3 | 1.1 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.3 | 1.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.3 | 2.4 | GO:0071694 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.3 | 1.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 | 0.8 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.3 | 2.0 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 3.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.2 | 2.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 | 3.2 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 1.9 | GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus(GO:0002562) somatic cell DNA recombination(GO:0016444) |
| 0.2 | 2.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
| 0.2 | 1.9 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
| 0.2 | 4.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.2 | 2.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.2 | 9.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 2.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 0.7 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.2 | 2.6 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.2 | 0.9 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.2 | 7.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.2 | 6.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 2.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 2.6 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.2 | 0.9 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.2 | 33.9 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.2 | 0.7 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.2 | 0.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 3.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.2 | 5.8 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 10.7 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.2 | 2.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.2 | 3.3 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
| 0.2 | 3.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 1.5 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 2.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 | 0.4 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.2 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 1.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 2.3 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.2 | 2.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 2.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 19.5 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.2 | 0.6 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.2 | 8.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.2 | 0.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.2 | 1.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.2 | 1.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.2 | 0.8 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.2 | 1.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
| 0.2 | 2.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 1.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 1.2 | GO:2000295 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of hydrogen peroxide catabolic process(GO:2000295) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 | 3.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 | 0.8 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 | 1.2 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.2 | 1.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 0.4 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.2 | 2.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.2 | 5.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 1.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 | 1.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 | 1.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 1.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 6.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 0.8 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 0.2 | 3.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 | 1.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 10.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.2 | 10.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 | 1.5 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 2.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.2 | 1.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 3.4 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
| 0.2 | 1.9 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.2 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.2 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 1.3 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 | 0.6 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.2 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 1.1 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 1.5 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 1.3 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
| 0.2 | 0.7 | GO:0032803 | viral protein processing(GO:0019082) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of neurotrophin production(GO:0032900) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.2 | 2.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 | 1.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 | 3.1 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 0.9 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 0.5 | GO:1903414 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.2 | 6.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 | 2.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
| 0.2 | 0.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.2 | 0.7 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.2 | 0.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 0.2 | 6.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.2 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 1.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.2 | 3.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.2 | 1.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.2 | 1.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.2 | 1.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 | 0.5 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.2 | 0.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.2 | 0.5 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.2 | 2.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.2 | 8.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.2 | 6.8 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.2 | 1.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.2 | 2.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 1.1 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
| 0.2 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 1.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 0.5 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.2 | 2.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.2 | 0.2 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
| 0.2 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 4.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.2 | 0.8 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 1.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 | 2.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.2 | 0.2 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 0.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 | 3.7 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.2 | 1.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.2 | 1.5 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.2 | 1.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.2 | 2.9 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 1.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.2 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 5.5 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 | 1.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 5.7 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.1 | 0.7 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.1 | 0.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 0.4 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.1 | 2.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.1 | 0.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 | 0.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 | 0.3 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.1 | 2.1 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 0.6 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 0.1 | 1.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 3.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 1.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 0.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 1.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.4 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.1 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.5 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.8 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.1 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 1.7 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.1 | 0.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 | 1.2 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.1 | 1.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 2.0 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.1 | 0.6 | GO:2000690 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 | 1.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.1 | 2.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.1 | 2.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.9 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 4.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.1 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 20.3 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 1.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 1.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.1 | 1.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.1 | 0.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 1.0 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.1 | 0.5 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 0.8 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 | 0.7 | GO:0090234 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.1 | 0.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 5.2 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 1.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.1 | 0.3 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) negative regulation of chronic inflammatory response(GO:0002677) |
| 0.1 | 2.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 5.2 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 0.7 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.2 | GO:0032660 | regulation of interleukin-17 production(GO:0032660) |
| 0.1 | 0.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.1 | 3.2 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
| 0.1 | 0.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.1 | 2.0 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 | 0.4 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.1 | 0.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.1 | 1.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.1 | 2.4 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 | 13.7 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.1 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.7 | GO:0060613 | fat pad development(GO:0060613) |
| 0.1 | 1.6 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 | 0.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.1 | 4.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 3.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 1.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 | 0.8 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 0.1 | 0.3 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 1.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 0.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.6 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 2.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.1 | 0.9 | GO:0002003 | angiotensin maturation(GO:0002003) |
| 0.1 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.1 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.4 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.1 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 1.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 0.8 | GO:0070922 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) small RNA loading onto RISC(GO:0070922) |
| 0.1 | 2.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.6 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.1 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.6 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.1 | 1.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.3 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 | 2.0 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 2.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 2.0 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.1 | 0.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 1.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.1 | 12.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 0.4 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.1 | 2.7 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 0.4 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.1 | 8.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 1.1 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
| 0.1 | 1.6 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.3 | GO:0090195 | chemokine secretion(GO:0090195) |
| 0.1 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.1 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 9.4 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.1 | 0.5 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 0.3 | GO:2000078 | type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.1 | 5.5 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 | 9.2 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 1.8 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.7 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 0.9 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 0.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.3 | GO:2000275 | cellular amide catabolic process(GO:0043605) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 | 0.9 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.1 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 2.4 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 | 0.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 | 0.4 | GO:0097490 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.1 | 4.1 | GO:0070671 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.7 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.1 | 1.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.1 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 1.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 3.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 1.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.3 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.1 | 0.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 1.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.5 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.1 | 0.9 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 1.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.4 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.5 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 1.9 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.1 | 0.6 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 3.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 2.7 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.9 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.1 | 0.7 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 | 0.6 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.6 | GO:0015867 | ADP transport(GO:0015866) ATP transport(GO:0015867) |
| 0.1 | 3.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.1 | 1.0 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 3.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.1 | 0.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 1.5 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.1 | 9.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.1 | 1.3 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.1 | 1.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.1 | 1.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 1.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 | 0.6 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 | 4.5 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
| 0.0 | 0.5 | GO:0072678 | T cell migration(GO:0072678) |
| 0.0 | 0.5 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 | 0.4 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.0 | 0.2 | GO:0021615 | specification of organ position(GO:0010159) glossopharyngeal nerve morphogenesis(GO:0021615) parathyroid gland development(GO:0060017) |
| 0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.0 | 1.0 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.0 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.6 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.0 | 0.1 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
| 0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 | 0.3 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.0 | 3.9 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 | 1.4 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
| 0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 1.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.0 | 0.8 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.7 | GO:0010039 | response to iron ion(GO:0010039) |
| 0.0 | 0.8 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.0 | 0.1 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.0 | 2.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.1 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 2.0 | GO:0060606 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
| 0.0 | 0.4 | GO:0042311 | vasodilation(GO:0042311) |
| 0.0 | 0.4 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.0 | 0.2 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.0 | 0.7 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 1.0 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
| 0.0 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 1.0 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.0 | 0.2 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.0 | 0.2 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 3.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.2 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 18.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.0 | 0.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.0 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.3 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.0 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.1 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.0 | 0.1 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 | 0.2 | GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter(GO:0060260) |
| 0.0 | 0.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.0 | 0.3 | GO:0050931 | pigment cell differentiation(GO:0050931) |
| 0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.8 | 47.5 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 4.2 | 21.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 3.7 | 37.0 | GO:0044194 | cytolytic granule(GO:0044194) |
| 3.2 | 38.5 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 2.8 | 28.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 2.7 | 13.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 2.2 | 46.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 2.0 | 6.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 2.0 | 54.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.9 | 7.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 1.8 | 7.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 1.8 | 21.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.7 | 10.1 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 1.6 | 4.7 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 1.5 | 100.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 1.5 | 16.5 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 1.5 | 4.4 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.3 | 33.8 | GO:0097342 | ripoptosome(GO:0097342) |
| 1.3 | 8.9 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.2 | 8.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 1.1 | 3.3 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 1.1 | 7.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 1.0 | 8.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 1.0 | 4.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.0 | 3.9 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 1.0 | 18.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.9 | 2.8 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.9 | 5.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.9 | 9.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.9 | 6.1 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.8 | 62.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.8 | 3.9 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.8 | 5.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.7 | 2.2 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.7 | 87.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.7 | 83.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.7 | 7.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.7 | 9.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.7 | 9.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.7 | 5.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.7 | 13.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.7 | 7.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.7 | 3.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.7 | 2.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.7 | 2.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.6 | 20.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.6 | 8.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 5.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.6 | 3.1 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.6 | 21.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.6 | 1.8 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.6 | 1.8 | GO:1990617 | CHOP-ATF4 complex(GO:1990617) |
| 0.6 | 97.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.6 | 5.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.6 | 1.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.6 | 1.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.6 | 2.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.6 | 5.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.5 | 1.0 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.5 | 50.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.5 | 3.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.5 | 3.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.5 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.5 | 13.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.5 | 5.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.5 | 12.2 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.5 | 9.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 3.5 | GO:0089701 | U2AF(GO:0089701) |
| 0.5 | 3.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.5 | 3.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.5 | 3.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.5 | 6.9 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.4 | 4.9 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.4 | 1.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.4 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.4 | 1.3 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.4 | 1.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.4 | 13.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.4 | 0.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.4 | 20.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 15.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.4 | 5.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 1.2 | GO:0016590 | ACF complex(GO:0016590) |
| 0.4 | 1.2 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.4 | 163.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.4 | 2.4 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 2.8 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.4 | 26.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.4 | 0.4 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.4 | 4.7 | GO:0016589 | NURF complex(GO:0016589) |
| 0.4 | 8.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.4 | 6.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 3.8 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.4 | 5.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 3.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 7.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 2.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.4 | 6.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.4 | 27.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.4 | 1.1 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.3 | 1.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.3 | 6.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.3 | 5.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.3 | 1.0 | GO:0097135 | X chromosome(GO:0000805) cyclin E2-CDK2 complex(GO:0097135) |
| 0.3 | 26.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 1.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 3.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.3 | 0.9 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.3 | 0.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.3 | 3.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.3 | 4.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 1.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.3 | 3.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 1.7 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 1.9 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 0.8 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 1.3 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
| 0.3 | 3.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.3 | 0.8 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.3 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.3 | 4.7 | GO:0097433 | dense body(GO:0097433) |
| 0.3 | 7.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 43.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.2 | 5.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 0.5 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.2 | 2.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.2 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 50.5 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.2 | 18.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.2 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 2.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.2 | 0.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 1.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.2 | 7.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 0.7 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 1.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.2 | 14.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 3.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.2 | 4.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 1.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.2 | 21.9 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.2 | 2.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 8.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.2 | 1.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 4.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 1.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 1.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.2 | 4.5 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.2 | 6.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 3.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 3.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 42.2 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.2 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 0.7 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 1.4 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.2 | 0.5 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.2 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 1.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.2 | 1.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 3.0 | GO:0032039 | integrator complex(GO:0032039) |
| 0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 1.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.2 | 2.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 2.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 6.0 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 1.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 0.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.2 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.2 | 1.5 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 1.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.1 | 3.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 0.6 | GO:1990879 | CST complex(GO:1990879) |
| 0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
| 0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.1 | 0.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 1.4 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 6.6 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.7 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 24.9 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 1.1 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 0.6 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 14.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 2.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 2.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 2.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 3.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 0.6 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.1 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.3 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 19.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 1.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.1 | 1.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 2.9 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 2.0 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.1 | 0.4 | GO:0097545 | axonemal outer doublet(GO:0097545) |
| 0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 3.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 2.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 0.8 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 1.4 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.1 | 1.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 6.1 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 0.8 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 2.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 49.4 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 3.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 3.3 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 4.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.4 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.1 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
| 0.1 | 2.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.1 | 0.7 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.1 | 1.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 8.3 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 4.3 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 0.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 9.1 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 7.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.1 | 1.4 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 6.6 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 1.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.0 | 0.7 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.0 | 13.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 2.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.0 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
| 0.0 | 0.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 5.3 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 7.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 80.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
| 0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 152.1 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.0 | 0.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.0 | 0.2 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 2.2 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 1.8 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.7 | 14.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 4.5 | 49.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 3.9 | 15.7 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 3.5 | 24.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 3.2 | 9.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 2.8 | 2.8 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
| 2.7 | 21.7 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 2.7 | 10.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 2.6 | 7.9 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 2.3 | 11.6 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 2.3 | 6.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 2.2 | 8.9 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 2.1 | 6.4 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 2.0 | 28.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 2.0 | 13.7 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 1.9 | 7.6 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 1.8 | 5.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.8 | 14.4 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 1.8 | 10.6 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
| 1.8 | 8.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.7 | 34.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.7 | 6.8 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.7 | 5.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
| 1.7 | 10.1 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.7 | 38.5 | GO:0005522 | profilin binding(GO:0005522) |
| 1.7 | 5.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 1.7 | 8.3 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 1.6 | 13.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 1.6 | 4.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.6 | 1.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 1.6 | 6.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.6 | 4.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.6 | 11.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 1.6 | 4.7 | GO:0098918 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 1.6 | 18.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.5 | 7.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.4 | 8.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.4 | 11.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.4 | 22.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.4 | 4.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 1.4 | 4.1 | GO:0044713 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 1.3 | 14.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 1.3 | 15.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.2 | 7.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.2 | 5.0 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
| 1.2 | 6.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.2 | 2.5 | GO:0032427 | GBD domain binding(GO:0032427) |
| 1.2 | 4.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 1.1 | 33.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.1 | 12.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 1.1 | 5.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.1 | 5.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.1 | 17.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 1.1 | 3.3 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 1.1 | 8.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.1 | 4.3 | GO:1990405 | protein antigen binding(GO:1990405) |
| 1.1 | 17.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 1.0 | 2.1 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 1.0 | 4.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.0 | 7.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.0 | 4.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 1.0 | 5.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 1.0 | 4.9 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 1.0 | 4.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.0 | 26.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.9 | 2.8 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.9 | 8.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.9 | 1.8 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.9 | 8.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.9 | 2.7 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.9 | 2.7 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.9 | 4.4 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
| 0.9 | 29.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.9 | 2.6 | GO:0008434 | calcitriol receptor activity(GO:0008434) lithocholic acid receptor activity(GO:0038186) calcitriol binding(GO:1902098) lithocholic acid binding(GO:1902121) |
| 0.9 | 8.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.9 | 3.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.9 | 7.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.9 | 4.3 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.9 | 3.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.8 | 5.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.8 | 4.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.8 | 5.0 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.8 | 9.9 | GO:0019864 | IgG binding(GO:0019864) |
| 0.8 | 2.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.8 | 2.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.8 | 5.6 | GO:0019862 | IgA binding(GO:0019862) |
| 0.8 | 26.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.8 | 13.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.8 | 3.1 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.8 | 54.0 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.8 | 23.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.8 | 3.1 | GO:0032560 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 0.8 | 2.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) interleukin-3 receptor binding(GO:0005135) |
| 0.8 | 6.0 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.7 | 11.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.7 | 6.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.7 | 27.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.7 | 2.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.7 | 9.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.7 | 7.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.7 | 6.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.7 | 10.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.7 | 3.4 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.7 | 2.7 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.7 | 30.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.7 | 12.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.7 | 2.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.6 | 10.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.6 | 4.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.6 | 27.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.6 | 3.8 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.6 | 1.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
| 0.6 | 2.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.6 | 5.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.6 | 3.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.6 | 7.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.6 | 4.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.6 | 1.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.6 | 5.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.6 | 37.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.6 | 1.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.6 | 3.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.6 | 7.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.6 | 10.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.6 | 3.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 4.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.5 | 132.2 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 6.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.5 | 1.6 | GO:0005369 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 0.5 | 21.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.5 | 25.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.5 | 9.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.5 | 4.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 5.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.5 | 2.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 1.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.5 | 1.5 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.5 | 3.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 3.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.5 | 11.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.5 | 4.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.5 | 14.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.5 | 2.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.5 | 15.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.5 | 11.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 2.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.5 | 4.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.5 | 5.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.5 | 2.8 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.5 | 2.7 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.5 | 2.7 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.5 | 3.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.5 | 1.4 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.4 | 2.2 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.4 | 1.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.4 | 44.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.4 | 3.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 1.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.4 | 1.3 | GO:0033746 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.4 | 3.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.4 | 5.5 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.4 | 23.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.4 | 7.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.4 | 1.3 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.4 | 4.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.4 | 2.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.4 | 2.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.4 | 2.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.4 | 3.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 0.8 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 1.5 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.4 | 1.1 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.4 | 3.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.4 | 11.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.4 | 1.1 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.4 | 3.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.4 | 6.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.4 | 2.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.4 | 15.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 1.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.3 | 1.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 3.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.3 | 0.7 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.3 | 11.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.3 | 6.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.3 | 1.7 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.3 | 8.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.3 | 0.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.3 | 6.5 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.3 | 11.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 3.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 7.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.3 | 1.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 1.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.3 | 1.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.3 | 12.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.3 | 1.0 | GO:0004618 | copper-exporting ATPase activity(GO:0004008) phosphoglycerate kinase activity(GO:0004618) copper-transporting ATPase activity(GO:0043682) |
| 0.3 | 1.3 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.3 | 23.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 1.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.3 | 4.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 2.5 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 1.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.3 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 2.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.3 | 5.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.3 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 0.9 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.3 | 59.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 0.9 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.3 | 4.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 5.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 1.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.3 | 1.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 6.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.3 | 7.4 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.3 | 12.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.3 | 2.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.3 | 1.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 2.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 3.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 4.8 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.3 | 0.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.3 | 1.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 1.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.3 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.3 | 6.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 14.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.3 | 10.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.3 | 1.3 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.3 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.3 | 2.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.3 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 8.1 | GO:0043394 | proteoglycan binding(GO:0043394) |
| 0.2 | 3.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.2 | 11.8 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.2 | 2.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.2 | 1.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.2 | 0.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 3.8 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 10.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.2 | 0.2 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.2 | 0.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.2 | 0.7 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.2 | 5.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 3.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.2 | 1.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 1.8 | GO:0019863 | IgE binding(GO:0019863) |
| 0.2 | 11.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.2 | 41.8 | GO:0005178 | integrin binding(GO:0005178) |
| 0.2 | 4.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.2 | 1.3 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.2 | 3.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 2.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 2.4 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.2 | 1.1 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.2 | 1.1 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.2 | 1.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 0.7 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.2 | 2.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 2.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 0.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 0.8 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.2 | 0.8 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 103.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 0.6 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.2 | 0.8 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 4.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 16.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 11.1 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 16.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 1.8 | GO:0070990 | snRNP binding(GO:0070990) |
| 0.2 | 1.9 | GO:0052724 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.2 | 1.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.2 | 2.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.5 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.2 | 0.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.2 | 2.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 0.7 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.2 | 2.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 1.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.2 | 0.5 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.2 | 2.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 1.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.2 | 1.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.2 | 3.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 0.7 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 0.2 | 5.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 2.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 1.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 0.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 0.5 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.2 | 1.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.2 | 0.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 0.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 12.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 2.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 0.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 1.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.2 | 0.5 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 1.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 1.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.2 | 3.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 10.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.2 | 1.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.2 | 42.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.2 | 2.3 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.2 | 3.4 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.2 | 9.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 4.0 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.2 | 3.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.2 | 1.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 4.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 13.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 5.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.3 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.1 | 8.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 5.4 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 1.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 1.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 2.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 4.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 2.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 2.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 6.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.1 | 0.8 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 7.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 1.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 5.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 3.2 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 3.1 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.5 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.1 | 1.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.6 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.1 | 1.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 0.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 0.4 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.1 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 1.6 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 4.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.1 | 3.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.7 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 45.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.4 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 1.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.1 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 0.3 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 1.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.1 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 2.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.1 | 2.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.5 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.1 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 1.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 2.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.1 | 3.0 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 2.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.3 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.1 | 0.4 | GO:0004641 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.1 | 2.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.1 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 1.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 3.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 4.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 0.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 2.4 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.3 | GO:0050473 | linoleate 13S-lipoxygenase activity(GO:0016165) arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.1 | 1.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.1 | 1.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 39.9 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 16.2 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 1.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 2.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 2.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 5.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 2.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 2.0 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 0.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 9.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.1 | 1.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.1 | 5.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 4.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.6 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 3.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 0.5 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.1 | 0.6 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 4.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 7.8 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.1 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.1 | 8.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 5.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 0.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
| 0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.5 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 4.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 1.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.0 | 0.5 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.0 | 3.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.1 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.0 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.0 | 1.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 1.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.2 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.0 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.0 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 7.1 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.0 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.0 | 1.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.0 | 1.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.0 | 20.6 | GO:0044212 | transcription regulatory region DNA binding(GO:0044212) |
| 0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.0 | 0.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.0 | 0.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 1.2 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 1.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.0 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.0 | 0.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 0.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 0.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.0 | 1.1 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.0 | 0.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.0 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.8 | 211.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.7 | 108.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.4 | 33.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 1.2 | 7.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 1.1 | 36.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 1.0 | 39.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.9 | 38.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.9 | 83.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.8 | 47.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.8 | 18.0 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.8 | 3.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.8 | 31.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.6 | 36.0 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.6 | 18.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.6 | 25.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.6 | 6.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.6 | 80.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.6 | 12.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.5 | 15.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.5 | 11.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.5 | 17.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.5 | 11.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.5 | 19.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.5 | 20.2 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.5 | 9.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.4 | 12.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.4 | 2.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.4 | 6.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.4 | 18.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.4 | 38.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.4 | 8.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.4 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 12.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 24.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.3 | 5.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 29.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 5.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.3 | 9.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.3 | 7.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 4.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.2 | 6.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.2 | 7.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 8.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 14.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 2.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 10.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 0.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 11.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.2 | 2.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 4.8 | PID FOXO PATHWAY | FoxO family signaling |
| 0.2 | 2.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.2 | 7.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 2.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 4.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 10.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 5.3 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 12.4 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 6.8 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 0.7 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 4.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 8.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 1.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 2.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 36.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 13.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.1 | 3.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 1.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 5.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 49.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 3.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 2.6 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.1 | 2.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 4.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 7.3 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 6.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 4.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.1 | 6.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 1.4 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 10.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 8.0 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 2.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.1 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 0.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 4.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 7.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 2.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 3.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 89.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 2.2 | 11.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 1.9 | 7.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 1.7 | 199.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 1.3 | 43.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 1.2 | 24.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 1.1 | 16.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 1.1 | 25.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 1.1 | 84.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 1.0 | 36.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.0 | 11.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.9 | 33.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.9 | 20.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 25.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.8 | 15.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.8 | 4.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.8 | 5.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.8 | 4.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.8 | 14.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.8 | 57.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.8 | 18.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.8 | 28.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.8 | 79.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.7 | 38.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.7 | 4.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.7 | 25.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
| 0.7 | 17.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.7 | 64.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.7 | 10.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.7 | 3.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.6 | 21.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.6 | 35.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.6 | 3.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.6 | 14.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.5 | 4.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.5 | 14.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.5 | 5.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.5 | 7.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.5 | 12.8 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.5 | 8.9 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.5 | 8.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.5 | 7.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 6.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.4 | 24.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.4 | 20.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.4 | 9.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.4 | 17.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.4 | 22.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.4 | 3.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.4 | 3.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.4 | 109.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.4 | 2.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 3.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 3.1 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.3 | 2.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.3 | 33.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.3 | 1.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.3 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.3 | 10.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 7.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.2 | 4.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 15.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.2 | 7.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 11.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 15.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.2 | 5.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 8.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 4.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 12.6 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.2 | 1.2 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 0.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 38.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.2 | 4.6 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.2 | 30.8 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.2 | 5.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 32.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.2 | 5.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 12.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.2 | 2.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.2 | 4.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 5.9 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 7.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 2.5 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.1 | 3.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.1 | 2.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 3.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 4.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.1 | 1.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 4.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 5.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 4.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 5.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 8.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 0.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 4.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 7.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 2.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 0.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 11.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 2.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.1 | 0.8 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
| 0.1 | 2.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 0.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 0.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.1 | 1.0 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.1 | 2.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 1.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.1 | 0.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.1 | 0.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.0 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.0 | 0.4 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.0 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 0.3 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.0 | 5.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.0 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 1.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.0 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.0 | 2.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.0 | 1.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 0.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 0.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 1.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |